XOMA Corp (XOMA)
25.34
-0.32
(-1.25%)
USD |
NASDAQ |
May 17, 16:00
25.34
0.00 (0.00%)
After-Hours: 20:00
XOMA Debt to Equity Ratio: 1.466 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 1.466 |
December 31, 2023 | 1.398 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.2307 |
December 31, 2020 | 0.2413 |
September 30, 2020 | 0.7873 |
June 30, 2020 | 0.8098 |
March 31, 2020 | 0.7668 |
December 31, 2019 | 0.7338 |
September 30, 2019 | 1.267 |
June 30, 2019 | 1.240 |
March 31, 2019 | 0.9398 |
December 31, 2018 | 1.197 |
September 30, 2018 | 19.11 |
June 30, 2018 | 3.061 |
March 31, 2018 | 2.585 |
Date | Value |
---|---|
December 31, 2017 | 2.518 |
September 30, 2017 | 3.525 |
June 30, 2017 | -0.9569 |
March 31, 2017 | -0.8532 |
December 31, 2016 | -0.9144 |
September 30, 2016 | -1.450 |
June 30, 2016 | -2.276 |
March 31, 2016 | -6.144 |
December 31, 2015 | -21.08 |
September 30, 2015 | -1.664 |
June 30, 2015 | -1.534 |
March 31, 2015 | -3.526 |
December 31, 2014 | 11.39 |
September 30, 2014 | -2.018 |
June 30, 2014 | -5.058 |
March 31, 2014 | 22.27 |
December 31, 2013 | -10.28 |
September 30, 2013 | -3.029 |
June 30, 2013 | -2.429 |
March 31, 2013 | -45.22 |
December 31, 2012 | 1.912 |
September 30, 2012 | -1.972 |
June 30, 2012 | 9.183 |
March 31, 2012 | 1.866 |
December 31, 2011 | 2.420 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2021
1.466
Maximum
Mar 2024
0.447
Average
0.1153
Median
Debt to Equity Ratio Benchmarks
Societal CDMO Inc (DELISTED) | 0.6323 |
AbbVie Inc | 9.242 |
AnaptysBio Inc | 0.00 |
Kinnate Biopharma Inc (DELISTED) | -- |
NovaBay Pharmaceuticals Inc | 6.294 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 219.42M |
Total Liabilities (Quarterly) | 137.08M |
Shareholders Equity (Quarterly) | 82.34M |
Current Ratio | 9.452 |
Net Debt Paydown Yield | -8.62% |